| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgement to Reviewers 2015
|
|
|
2016
|
15 |
2 |
p. 135-138
4 p.
|
artikel
|
| 2 |
Advanced curriculum for cystic fibrosis: Integrating genomic-driven data into patient-centered treatment strategies
|
Stuart Elborn, J.
|
|
2016
|
15 |
2 |
p. e22-e23
nvt p.
|
artikel
|
| 3 |
An evaluation strategy for potential QTc prolongation with chronic azithromycin therapy in cystic fibrosis
|
Lenehan, Patrick John
|
|
2016
|
15 |
2 |
p. 192-195
4 p.
|
artikel
|
| 4 |
A novel culture medium for isolation of rapidly-growing mycobacteria from the sputum of patients with cystic fibrosis
|
Preece, Clair L.
|
|
2016
|
15 |
2 |
p. 186-191
6 p.
|
artikel
|
| 5 |
Anti-Pseudomonas aeruginosa IgY antibodies augment bacterial clearance in a murine pneumonia model
|
Thomsen, K.
|
|
2016
|
15 |
2 |
p. 171-178
8 p.
|
artikel
|
| 6 |
A randomized controlled trial of vitamin D replacement strategies in pediatric CF patients
|
Simoneau, Tregony
|
|
2016
|
15 |
2 |
p. 234-241
8 p.
|
artikel
|
| 7 |
Burkholderia cepacia selective agar can be useful for recovery of Exophiala dermatitidis from sputum samples of cystic fibrosis patients
|
Raclavsky, Vladislav
|
|
2016
|
15 |
2 |
p. e19-
1 p.
|
artikel
|
| 8 |
Causes of death in French cystic fibrosis patients: The need for improvement in transplantation referral strategies!
|
Martin, Clémence
|
|
2016
|
15 |
2 |
p. 204-212
9 p.
|
artikel
|
| 9 |
Cystic fibrosis in young children: A review of disease manifestation, progression, and response to early treatment
|
VanDevanter, Donald R.
|
|
2016
|
15 |
2 |
p. 147-157
11 p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2016
|
15 |
2 |
p. ii-
1 p.
|
artikel
|
| 11 |
Faecal proteomics: A tool to investigate dysbiosis and inflammation in patients with cystic fibrosis
|
Debyser, Griet
|
|
2016
|
15 |
2 |
p. 242-250
9 p.
|
artikel
|
| 12 |
Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes
|
Boudreau, Valérie
|
|
2016
|
15 |
2 |
p. 258-260
3 p.
|
artikel
|
| 13 |
HbA1c: An effective screening tool for cystic fibrosisrelated diabetes?
|
Schnyder, Marie-Angela
|
|
2016
|
15 |
2 |
p. 261-262
2 p.
|
artikel
|
| 14 |
HbA1c as a screening tool for cystic fibrosis related diabetes
|
Burgess, Juliana C.
|
|
2016
|
15 |
2 |
p. 251-257
7 p.
|
artikel
|
| 15 |
Inhaled alpha1-proteinase inhibitor therapy in patients with cystic fibrosis
|
Gaggar, Amit
|
|
2016
|
15 |
2 |
p. 227-233
7 p.
|
artikel
|
| 16 |
Limited premature termination codon suppression by read-through agents in cystic fibrosis intestinal organoids
|
Zomer-van Ommen, D.D.
|
|
2016
|
15 |
2 |
p. 158-162
5 p.
|
artikel
|
| 17 |
Molecular epidemiology of Mycobacterium abscessus complex isolates in Ireland
|
O'Driscoll, C.
|
|
2016
|
15 |
2 |
p. 179-185
7 p.
|
artikel
|
| 18 |
New insights into disease progression for the CFTR modulator-treated cystic fibrosis patient
|
McColley, Susanna A.
|
|
2016
|
15 |
2 |
p. e21-
1 p.
|
artikel
|
| 19 |
News
|
|
|
2016
|
15 |
2 |
p. 145-146
2 p.
|
artikel
|
| 20 |
Optical coherence tomography detects structural abnormalitiesof the nasal mucosa in patients with cystic fibrosis
|
Oltmanns, Ute
|
|
2016
|
15 |
2 |
p. 216-222
7 p.
|
artikel
|
| 21 |
Piperacillin/tazobactam continuous infusion at 12G/1.5G per day in CF patients results in target plasma-concentrations
|
Öbrink-Hansen, Kristina
|
|
2016
|
15 |
2 |
p. e13-e14
nvt p.
|
artikel
|
| 22 |
Predictors of non-referral of patients with cystic fibrosisfor lung transplant evaluation in the United States
|
Ramos, Kathleen J.
|
|
2016
|
15 |
2 |
p. 196-203
8 p.
|
artikel
|
| 23 |
Referral to lung transplantation- too little, too late
|
Aaron, Shawn D.
|
|
2016
|
15 |
2 |
p. 143-144
2 p.
|
artikel
|
| 24 |
Renin-associated hypertension after bronchial artery embolization in cystic fibrosis
|
Coolen, Nathalie
|
|
2016
|
15 |
2 |
p. 213-215
3 p.
|
artikel
|
| 25 |
Replies to “Is the home environment an important factor in the occurrence of fungal events in cystic fibrosis?”
|
Rocchi, Steffi
|
|
2016
|
15 |
2 |
p. e17-e18
nvt p.
|
artikel
|
| 26 |
Response to Letter to the Editor: HbA1c as a screening tool for cystic fibrosis related diabetes
|
Burgess, Juliana C.
|
|
2016
|
15 |
2 |
p. 265-266
2 p.
|
artikel
|
| 27 |
Serum retinol and pulmonary function in young people with cystic fibrosis
|
Rivas-Crespo, M. Francisco
|
|
2016
|
15 |
2 |
p. e15-
1 p.
|
artikel
|
| 28 |
Serum retinol levels and pulmonary function in children and adolescents with cystic fibrosis
|
Woestenenk, J.W.
|
|
2016
|
15 |
2 |
p. e16-
1 p.
|
artikel
|
| 29 |
Single-cell high resolution melting analysis: A novel, generic, pre-implantation genetic diagnosis (PGD) method applied to cystic fibrosis (HRMA CF-PGD)
|
Destouni, A.
|
|
2016
|
15 |
2 |
p. 163-170
8 p.
|
artikel
|
| 30 |
Sugar Substitute?
|
Blackman, Scott M.
|
|
2016
|
15 |
2 |
p. 141-142
2 p.
|
artikel
|
| 31 |
The effect of CFTR modulation on the disease progression of cystic fibrosis in the era of precision medicine
|
Stuart Elborn, J.
|
|
2016
|
15 |
2 |
p. e20-
1 p.
|
artikel
|
| 32 |
The 1-min sit-to-stand test—A simple functional capacity test in cystic fibrosis?
|
Radtke, Thomas
|
|
2016
|
15 |
2 |
p. 223-226
4 p.
|
artikel
|
| 33 |
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
|
Flume, Patrick A.
|
|
2016
|
15 |
2 |
p. 139-140
2 p.
|
artikel
|
| 34 |
Using HbA1c as a screening tool for Cystic Fibrosis Related Diabetes
|
Widger, John
|
|
2016
|
15 |
2 |
p. 263-264
2 p.
|
artikel
|
Tijdschrift beschrijving